Artisan discloses 7.9% Veracyte (VCYT) stake held for clients
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Artisan Partners has filed Amendment No. 5 to report its ownership in Veracyte, Inc. The Artisan entities report beneficial ownership of 6,263,041 shares of Veracyte common stock, representing 7.9% of the class, based on 79,049,173 shares outstanding as of 10/31/2025.
The group has shared voting power over 5,457,186 shares and shared dispositive power over 6,263,041 shares, with no sole voting or dispositive power. The shares were acquired on behalf of discretionary clients of Artisan Partners Limited Partnership, and the filing states they are held in the ordinary course of business, not for the purpose of changing or influencing control of Veracyte.
Positive
- None.
Negative
- None.
FAQ
What ownership stake in Veracyte (VCYT) does Artisan report in this Schedule 13G/A?
Artisan reports beneficial ownership of 6,263,041 Veracyte common shares, representing 7.9% of the outstanding class, based on 79,049,173 shares outstanding as of October 31, 2025. This reflects a sizable institutional position in the company’s equity.
Who are the reporting persons in Artisan’s Schedule 13G/A for Veracyte (VCYT)?
The filing lists Artisan Partners Asset Management Inc., Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership as reporting persons. They are affiliated Delaware entities forming the asset management complex reporting the Veracyte share ownership.
Does Artisan seek control of Veracyte (VCYT) according to this Schedule 13G/A?
The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Veracyte. It expressly disclaims acquisition in connection with any control-related transaction.
What is Artisan Partners Limited Partnership’s role in this Veracyte (VCYT) filing?
Artisan Partners Limited Partnership is identified as a registered investment adviser under the Investment Advisers Act of 1940. It manages discretionary client accounts on whose behalf the Veracyte shares were acquired and is one of the joint reporting persons.